Search

everythinglearnresearchcommunity

for

Search:↓

This type of hair loss is probably often missed and treatments reducing inflammation might work well.

Early intervention and patient education are crucial for managing alopecia areata.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

Standardized data is essential for diagnosing scalp and hair conditions in males.

A man with a new type of male pattern hair loss that affects the back of the head responded well to common hair loss treatments.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

About 61% of women who had COVID-19 experienced hair loss afterward.

A baby girl has a hair disorder called monilethrix, causing fragile hair that may improve over time.

Effective hair loss treatment requires personalized approaches and patient-provider collaboration.

Anxiety can cause significant hair loss in children.

Hair loss can indicate various health issues, including serious diseases, hormonal imbalances, and can significantly affect personal life and mental health.

New imaging tools help doctors better examine hair and scalp health without surgery.

Non-invasive methods can effectively diagnose and manage alopecia areata.

Doctors should use thorough examinations and more research to better diagnose alopecia in patients with skin of color.

The oral supplement improved hair loss in patients with telogen effluvium.

A woman's rare hair loss condition improved on its own, suggesting this type might recover like common cases.

The serum is safe and effective for treating hair loss.

New understanding and treatments for hair loss are improving, but more research is needed.

COVID-19 reinfection may trigger alopecia areata.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Some children may develop hair loss after having COVID-19.

Many patients experienced severe hair loss after COVID-19, especially older adults and women.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Hair loss in women can improve with iron and vitamin supplements if caused by iron deficiency.

A woman's hair grew back after treatment for a rare hair loss caused by proton therapy.